Bravecto Spot-On Cat Purple 6.25-12.5kg 250mg (2 pack)
Statement of claims:
- Treatment and prevention of flea (Ctenocephalides felis) infestations for up to 3 months
- Treatment and control of paralysis tick (Ixodes holocyclus) for 3 months
- Rapid onset of action kills newly emerged adult fleas before they lay eggs
- Reduces incidence of flea allergy dermatitis (FAD) by controlling adult fleas
BRAVECTO Spot-on contains fluralaner, a member of the antiparasitic class of isoxazolinesubstituted benzamide derivatives. Fluralaner acts antagonistically on arthropods ligandgated chloride channels (GABA-receptor and glutamate-receptor).
BRAVECTO Spot-on is effective against fipronil-resistant strains of fleas.
The safe use of BRAVECTO Spot On for Cats in breeding males and females has not been established.
ONSET OF ACTION AND EFFICACY BRAVECTO Spot-on kills pre-existing and new infestations of paralysis ticks (Ixodes holocyclus) for 3 months.
BRAVECTO Spot-on provides effective treatment and prevention of fleas on cats for up to 3 months following application. Fleas are killed in up to 12 hours after treatment or after reinfestation during the 3 month treatment period. The flea life cycle can be broken by the rapid onset of action and the long-lasting efficacy against adult fleas on the cat. Newly emerged adult fleas on a cat are killed before viable eggs are produced.
BRAVECTO Spot-on effectively controls environmental flea populations in areas to which the cat has access.
Ixodes holocyclus ticks do not occur in Western Australia. In tick season daily searching for and removal of any ticks found is recommended.
|Indication||Highly palatable, easy to administer chew for treatment and prevention of flea infestations ( Ctenocephalides felis ) for three months; treatment and control of paralysis tick ( Ixodes holocyclus ) for four months; treatment and control of brown dog tick ( Rhipicephalus sanguineus ) for eight weeks.Treatment and control of demodicosis (demodectic mange) caused by Demodex sp. mite infestations for up to three months; treatment and control of sarcoptic mange (Sarcoptes scabiei) infestations for up to one month; treatment and control of ear mite (Otodectes cynotis) infestations for up to one month.|
|Actions||Fluralanar is a member of the antiparasitic class of isoxazoline substituted benzamide derivatives. Fluralaner acts antagonistically on the ligand gated chloride channels (γ-aminobutyric acid receptors and glutamate receptors) of arthropods. Bravecto has a rapid onset of action, killing newly emerged adult fleas before they lay eggs, and reduces the incidence of flea allergy dermatitis by controlling adult fleas. Bravecto provides effective control of fleas on dogs within eight hours of administration and effective control of pre-existing infestations of paralysis ticks within 24 hours.|
|Precautions||Bravecto should not be used in puppies less than 8 weeks of age or weighing less than 2 kg.May irritate the eyes and skin. Avoid contact with eyes and skin. Wash hands after use.First Aid If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131 126.Disposal Dispose of foil and carton by wrapping with paper and putting in garbage.|
|Dosage and Administration||Bravecto is available in five sizes (for very small dogs 2 to 4.5 kg, small dogs > 4.5 to 10 kg, medium dogs > 10 to 20 kg, large dogs > 20 to 40 kg, and very large dogs > 40 to 56 kg) and within each weight range, a whole tablet must be used. For dogs weighing more than 56 kg, use a combination of two tablets that most closely matches the bodyweight. In dogs older than 8 weeks, treatment every eight weeks has been shown to be well tolerated. Administer Bravecto at or around the time of feeding. Bravecto is readily consumed by most dogs when given by the owner. Bravecto can be given with food or administered in the same way as other tablets. Bravecto can be used in breeding, pregnant and lactating dogs.|
|Storage||Store below 30°C (room temperature).|
|Manufacturer||MSD Animal Health|